Related Experiment Video
Updated: Jun 3, 2026

Induction and Validation of Cellular Senescence in Primary Human Cells
Published on: June 20, 2018
Insights into 4E-BP1 and p53 mediated regulation of accelerated cell senescence
Suzan K Chao1, Susan Band Horwitz, Hayley M McDaid
1Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Abstract:
Senescence is a valid tumor suppressive mechanism in cancer. Accelerated cell senescence describes the growth arrested state of cells that have been treated with anti-tumor drugs, such as doxorubicin that induce a DNA damage response. Discodermolide, a microtubule-stabilizing agent, is a potent inducer of accelerated cell senescence. Resistance to discodermolide is mediated via resistance to accelerated cell senescence, and is associated with reduced expression of the mTORC1 substrate, 4E-BP1 and increased expression of p53 [1]. Although the association of p53 with senescence induction is well-characterized, senescence reversion in the presence of high expression of p53 has not been well-documented. Furthermore, studies addressing the role of mTOR signaling in regulating senescence have been limited and recent data implicate a novel, senescence-associated role for 4E-BP1 in crosstalk with the transcription factor p53. This research perspective will address these somewhat contradictory findings and summarize recent research regarding senescence and mTORC1 signaling.
Insights
Accelerated cell senescence, a cancer growth arrest, can be reversed even with high p53. This study explores the novel role of 4E-BP1 in senescence and its crosstalk with p53.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Senescence is a tumor suppressive mechanism.
- Accelerated cell senescence is induced by anti-tumor drugs like doxorubicin.
- Discodermolide induces senescence; resistance is linked to 4E-BP1 and p53 expression.
Purpose of the Study:
- To address contradictory findings on senescence reversion with high p53.
- To summarize research on senescence and mTORC1 signaling.
- To investigate the novel role of 4E-BP1 in senescence and its crosstalk with p53.
Main Methods:
- Literature review and synthesis of existing research.
- Analysis of molecular mechanisms regulating senescence.
- Exploration of the mTORC1 pathway's role in cell fate.
Main Results:
- Senescence reversion can occur despite high p53 expression.
- Reduced 4E-BP1 and increased p53 are associated with resistance to senescence.
- A novel senescence-associated role for 4E-BP1 in crosstalk with p53 is implicated.
Conclusions:
- The interplay between p53, 4E-BP1, and mTORC1 signaling is crucial in regulating senescence.
- Further research is needed to fully understand senescence reversion mechanisms.
- Targeting these pathways may offer new therapeutic strategies for cancer treatment.
More Related Videos
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
07:39SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
Related Concept Videos
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Replicative Cell Senescence
Replicative Cell Senescence